1. Li, Ting, Guan, Lei, Tang, Guangbo, Li, Xinyuan, Zhang, Huqin. 2021. Downregulation of TMEM220 promotes tumor progression in Hepatocellular Carcinoma. In Cancer gene therapy, 29, 835-844. doi:10.1038/s41417-021-00370-0. https://pubmed.ncbi.nlm.nih.gov/34321624/
2. Choi, Boram, Han, Tae-Su, Min, Jimin, Kim, Young-Joon, Yang, Han-Kwang. 2016. MAL and TMEM220 are novel DNA methylation markers in human gastric cancer. In Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 22, 35-44. doi:10.1080/1354750X.2016.1201542. https://pubmed.ncbi.nlm.nih.gov/27329150/
3. Cao, Cong, Li, Jun, Li, Guangzhi, Li, Jiequn, Cao, Song. 2021. Long Non-coding RNA TMEM220-AS1 Suppressed Hepatocellular Carcinoma by Regulating the miR-484/MAGI1 Axis as a Competing Endogenous RNA. In Frontiers in cell and developmental biology, 9, 681529. doi:10.3389/fcell.2021.681529. https://pubmed.ncbi.nlm.nih.gov/34422806/
4. Zhu, Liangyu, Sun, Hongyu, Tian, Guo, Yang, Lei, Liu, Guangjie. 2021. Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes. In Aging, 13, 16600-16619. doi:10.18632/aging.203179. https://pubmed.ncbi.nlm.nih.gov/34182539/
5. Chen, Fei, Peng, Xing, Teng, Zhipeng, Long, Haibo, Wu, Haibo. 2022. Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma. In Evidence-based complementary and alternative medicine : eCAM, 2022, 3709823. doi:10.1155/2022/3709823. https://pubmed.ncbi.nlm.nih.gov/36248415/
智鼠故事 
